| Product Code: ETC12463401 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Imatinib Drug Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Imatinib Drug Market - Industry Life Cycle |
3.4 South Africa Imatinib Drug Market - Porter's Five Forces |
3.5 South Africa Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 South Africa Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 South Africa Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 South Africa Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 South Africa Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 South Africa Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in South Africa |
4.2.2 Growing awareness and access to healthcare services |
4.2.3 Rising investment in research and development of cancer treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals |
4.3.2 High cost associated with cancer treatments |
4.3.3 Competition from generic drug manufacturers |
5 South Africa Imatinib Drug Market Trends |
6 South Africa Imatinib Drug Market, By Types |
6.1 South Africa Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 South Africa Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 South Africa Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 South Africa Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 South Africa Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 South Africa Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 South Africa Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 South Africa Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 South Africa Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 South Africa Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 South Africa Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 South Africa Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 South Africa Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 South Africa Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 South Africa Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 South Africa Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 South Africa Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 South Africa Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 South Africa Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 South Africa Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 South Africa Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 South Africa Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 South Africa Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 South Africa Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 South Africa Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 South Africa Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 South Africa Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 South Africa Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 South Africa Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 South Africa Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 South Africa Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 South Africa Imatinib Drug Market Import-Export Trade Statistics |
7.1 South Africa Imatinib Drug Market Export to Major Countries |
7.2 South Africa Imatinib Drug Market Imports from Major Countries |
8 South Africa Imatinib Drug Market Key Performance Indicators |
8.1 Patient survival rates |
8.2 Adoption rates of imatinib drug in cancer treatment protocols |
8.3 Number of clinical trials and research studies involving imatinib in South Africa |
9 South Africa Imatinib Drug Market - Opportunity Assessment |
9.1 South Africa Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 South Africa Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 South Africa Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 South Africa Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 South Africa Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 South Africa Imatinib Drug Market - Competitive Landscape |
10.1 South Africa Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 South Africa Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here